These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 14765321

  • 21. [A Case of Invasive Intraductal Papillary Mucinous Carcinoma, Penetrating the Stomach, Colon, and Jejunum].
    Goto T, Toyama H, Asari S, Terai S, Kinoshita H, Matsumoto T, Kuramitsu K, Tanaka M, Takebe A, Kido M, Matsumoto I, Ajiki T, Fukumoto T, Ku Y.
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2391-3. PubMed ID: 26805374
    [Abstract] [Full Text] [Related]

  • 22. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.
    Hepatogastroenterology; 2005 Nov; 52(62):398-403. PubMed ID: 15816444
    [Abstract] [Full Text] [Related]

  • 23. Virtual CO2 MDCT pancreatography: a new feasible technique for minimally invasive pancreatectomy in intraductal papillary mucinous neoplasms.
    Sugimoto M, Yasuda H, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Takenoue T, Yamamoto S, Watayo Y, Yagawa Y, Tsuchiya T.
    Hepatogastroenterology; 2008 Nov; 55(81):270-4. PubMed ID: 18507123
    [Abstract] [Full Text] [Related]

  • 24. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma.
    Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK.
    AJR Am J Roentgenol; 2006 Mar; 186(3):687-95. PubMed ID: 16498096
    [Abstract] [Full Text] [Related]

  • 25. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.
    Kim SY, Lee JM, Kim SH, Shin KS, Kim YJ, An SK, Han CJ, Han JK, Choi BI.
    AJR Am J Roentgenol; 2006 Nov; 187(5):1192-8. PubMed ID: 17056905
    [Abstract] [Full Text] [Related]

  • 26. Intraductal papillary-mucinous neoplasm of the pancreas penetrating to the stomach and the common bile duct.
    Goto N, Yoshioka M, Hayashi M, Itani T, Mimura J, Hashimoto K.
    JOP; 2012 Jan 10; 13(1):61-5. PubMed ID: 22233949
    [Abstract] [Full Text] [Related]

  • 27. Pancreatic intraductal papillary mucinous neoplasm invading the duodenum: a case report and a review of the literature.
    DʼOnofrio M, Tinazzi Martini P, De Robertis R, Pregarz M, Girelli R, Pederzoli P, Pozzi Mucelli R.
    Pancreas; 2014 Apr 10; 43(3):490-1. PubMed ID: 24622089
    [No Abstract] [Full Text] [Related]

  • 28. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
    Nakata K, Nagai E, Ohuchida K, Hayashi A, Miyasaka Y, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.
    Hum Pathol; 2010 Jun 10; 41(6):824-31. PubMed ID: 20153506
    [Abstract] [Full Text] [Related]

  • 29. Protruded duodenal tumor arising from Santorini's duct of the pancreas: a rare case of intraductal papillary mucinous neoplasm mimicking a duodenal polypoid tumor.
    Komatsubara H, Kato H, Noguchi D, Gyoten K, Hayasaki A, Iizawa Y, Fujii T, Tanemura A, Murata Y, Kuriyama N, Kishiwada M, Sakurai H, Mizuno S.
    BMC Gastroenterol; 2020 Sep 16; 20(1):303. PubMed ID: 32938427
    [Abstract] [Full Text] [Related]

  • 30. Postoperative recurrence from tract seeding after use of EUS-FNA for preoperative diagnosis of cancer in pancreatic tail.
    Sakamoto U, Fukuba N, Ishihara S, Sumi S, Okada M, Sonoyama H, Ohshima N, Moriyama I, Kawashima K, Kinoshita Y.
    Clin J Gastroenterol; 2018 Jun 16; 11(3):200-205. PubMed ID: 29392646
    [Abstract] [Full Text] [Related]

  • 31. Endoscopic ultrasonography of duodenal aberrant pancreas: comparison with histology after endoscopic resection.
    Watanabe T, Aoyagi K, Tomioka Y, Ishibashi H, Nimura S, Sakisaka S.
    J Med Ultrason (2001); 2015 Apr 16; 42(2):277-80. PubMed ID: 26576585
    [Abstract] [Full Text] [Related]

  • 32. Surgical treatment of intraductal papillary-mucinous tumor (IPMT) of the pancreas: operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT.
    Seki M, Yanagisawa A, Ohta H, Ninomiya Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Ninomiya E, Takano K, Aruga A, Yamada K, Sasaki K, Kato Y.
    J Hepatobiliary Pancreat Surg; 2003 Apr 16; 10(2):147-55. PubMed ID: 14505148
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.
    Hum Pathol; 2010 Oct 16; 41(10):1466-74. PubMed ID: 20619441
    [Abstract] [Full Text] [Related]

  • 36. Intraductal papillary-mucinous tumor of the pancreas: the clinical research continues.
    Pezzilli R.
    JOP; 2004 Jan 16; 5(1):53-5. PubMed ID: 14730125
    [No Abstract] [Full Text] [Related]

  • 37. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H, Ku Y, Azuma T.
    J Clin Gastroenterol; 2010 Oct 16; 44(9):e224-9. PubMed ID: 20453661
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N, Sato N, Mori Y, Tamura T, Higure A, Yamaguchi K.
    Eur J Surg Oncol; 2013 Jun 16; 39(6):554-8. PubMed ID: 23506840
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.